Attached files

file filename
8-K/A - VASO Corpvaso8ka-sept42011.htm
EX-99.2 - VASOMEDICAL UNAUDITED PROFORMA FINANCIALS - VASO Corpvaso8kaproforma-ex992.htm
EX-99.1.4 - PJM UNAUDITED FINANCIALS 6/30/11 - VASO Corpvaso8ka-pjm2011ex9914.htm
EX-99.1.2 - PJM AUDITED FINANCIALS 12/31/10 - VASO Corpvaso8ka-pjm2010ex9912.htm
EX-99.1.1 - BIOX AUDITED FINANCIALS 12/31/10 - VASO Corpvaso8ka-biox2010ex9911.htm

BIOX INSTRUMENTS CO.,LTD
                 
    PROFIT AND LOSS STATEMENT
                 
FOR THE SIX MONTHS ENDED JUNE 30, 2011 AND 2010
             
                   
ITEMS
 
LINE
   
2011.1~2011.6
RMB
   
2010.1~2010.6
RMB
 
Sales
    1       4,236,574.53       3,515,004.45  
      Including: Export sales
    2                  
Less: Sales discounts and allowances
    3                  
Net sales
    4       4,236,574.53       3,515,004.45  
Less: Sales tax
    5       65,679.26       50,097.75  
         Cost of sales
    6       825,884.87       943,781.43  
                Including: Cost of export sales
    7                  
Gross profit on sales
    8       3,345,010.40       2,521,125.27  
Less: Selling expenses
    9       1,008,887.56       1,186,542.67  
         General and administrative expenses
    10       569,547.72       558,315.42  
         Financial expenses
    11       (4,531.99 )     (25,188.30 )
               Including : Interest expenses (less interest income)
    12                  
                                Exchange loss (less exchange gains)
    13                  
Profit on sales
    14       1,771,107.11       801,455.48  
Add: Income from other operations
    15                  
Operating profit
    16       1,771,107.11       801,455.48  
Add: Investing gains
    17                  
        Non-operating income
    18       138,166.54          
Less: Non-operating expenses
    19       69,586.58       8,749.19  
Add: Profit and loss adjustment for previous years
    20                  
TOTAL PROFIT
    21       1,839,687.07       792,706.29  
Less: Income tax
    22       52,957.17          
NET PROFIT
    23       1,786,729.90       792,706.29  
                         

 
1

 
BIOX INSTRUMENTS CO.,LTD
                           
BALANCE SHEET
                           
            2011-06-30            
                           
ER@2011.6.30
 
ASSETS
 
LINE
   
Bal.E/P(RMB)
   
LIABILITIES AND OWNERS'EQUITY
 
LINE
   
Bal.E/P(RMB)
 
CURRENT ASSETS
    1            
CURRENT LIABILITIES
    1        
Cash on hand
    2       14,362.58    
Short term loans
    2        
Cash in bank
    3       2,873,681.50    
Notes payable
    3        
Marketable securities
    4            
Accounts payable
    4       89,903.74  
Notes receivable
    5            
Accrued payroll
    5          
Accounts receivable
    6       477,349.45    
Taxes payable
    6       578,994.60  
      Less:Allowance for bad debts
    7            
Dividends payable
    7          
Etrust bank to make collections
    8            
Advances received
    8       2,148,650.00  
Advances to suppliers
    9            
Other payables
    9       125,580.03  
Other receivables
    10       584,492.77    
Accured expenses
    10       (100,000.00 )
Prepaid and deferred expenses
    11            
Bonus and welfare funds for staff and workers
    11          
Inventories
    12       1,928,165.89    
Long term liabilities payable at maturity within a year
    12          
    Less:Allowance for loss on realization of stock
    13            
Other current liabilities
    13          
Long term investment recovery due within a year
    14                   14          
Other current assets
    15                   15          
Total current assets
    16       5,878,052.19    
Total current liabilities
    16       2,843,128.37  
LONG TERM INVESTMENT
    17            
LONG TERM LIABILITIES
    17          
Long term investment
    18            
Long term loans
    18          
Receivables over a year
    19            
Bond payable
    19          
FIXED ASSETS
    20            
Premium(discount) on bond payable
    20          
 Fixed assets-cost
    21       390,301.31    
Payable over a year
    21          
      Less:accumulated depreciation
    22       293,329.88    
OTHER LIABILITIES
    22          
Fixed assets-net value
    23       96,971.43    
Exchange gain during preparation period
    23          
Disposal of fixed assets
    24            
Deferred investment income
    24          
CONSTRUCTION WORK IN PROCESS
    25            
Deferred lease income
    25          
Construction work in process
    26            
Credit item of deferred tax
    26          
INTANGIBLE ASSETS
    27            
Other deferred credits
    27          
Right to the use of site
    28            
Exchange gain to be written off
    28          
Industrial property and proprietary technology
    29            
Total liabilities
    29       2,843,128.37  
Other intangible assets
    30            
OWNER'S EQUITY
    30          
Total intangible assets
    31       0           31          
OTHER ASSETS
    32            
Paid in capital
    32       500,000.00  
Organization expenses
    33            
Including: Foreign investment
    33          
Exchange loss during preparation period
    34            
Less:repayment of investment
    34          
Deferred investment losses
    35            
Translation reserve
    35          
Debit item of deferred tax
    36            
Reserve fund
    36          
Other deferred expenses
    37            
Expansion fund
    37          
Exchange loss to be writton off
    38            
Repayment of investment by profit
    38          
      39            
Current year profit
    39       2,446,029.77  
      40            
Retained earnings
    40       185,865.48  
Total other assets
    41       0    
Total owners' equity
    41       3,131,895.25  
TOTAL ASSETS
    42       5,975,023.62    
TOTAL LIABILITIES AND OWNERS’ EQUITY
    42       5,975,023.62  
 
2